Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background/Aims: Toll-like receptors (TLRs) modulate T cell responses in diverse diseases. Co-stimulation of T cell activation via TLR9 induces production of interferon gamma (IFN-γ), priming of which is critical for differentiation of proinflammatory macrophages. These macrophages have a crucial role in nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the expression of TLR9 protein on T cells and the consequences of TLR9-mediated triggering of these cells in patients with NAFLD. Methods: Our study included 34 patients with simple steatosis, 34 patients with nonalcoholic steatohepatitis, eight patients with NAFLD who met general diagnostic criteria but lacked histological diagnosis, and 51 control subjects. We used a synthetic TLR9 ligand to co-stimulate T cells. We measured TLR9 expression in liver and peripheral T cells and CD69 and IFN-γ as phenotypic markers of T cell activation and differentiation by flow cytometry. Results: TLR9 expression on liver and peripheral T cells was lowest in patients with simple steatosis and was positively associated with anthropometric, biochemical, and histopathological features of NAFLD. In vitro co-stimulation of T cells from patients with simple steatosis induced a limited number of IFN-γ-producing CD8+ T cells. At baseline, these patients showed a low frequency of circulating type 1 CD8+ cells. Conclusions: The positive associations between TLR9 and anthropometric, clinical, and histological features and the crucial role of IFN-γ-in NAFLD suggest that limited TLR9 expression and production of IFN-γ play a protective role in patients with simple steatosi
Abstract
Background/Aims: Toll-like receptors (TLRs) modulate T cell responses in diverse diseases. Co-stimulation of T cell activation via TLR9 induces production of interferon gamma (IFN-γ), priming of which is critical for differentiation of proinflammatory macrophages. These macrophages have a crucial role in nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the expression of TLR9 protein on T cells and the consequences of TLR9-mediated triggering of these cells in patients with NAFLD. Methods: Our study included 34 patients with simple steatosis, 34 patients with nonalcoholic steatohepatitis, eight patients with NAFLD who met general diagnostic criteria but lacked histological diagnosis, and 51 control subjects. We used a synthetic TLR9 ligand to co-stimulate T cells. We measured TLR9 expression in liver and peripheral T cells and CD69 and IFN-γ as phenotypic markers of T cell activation and differentiation by flow cytometry. Results: TLR9 expression on liver and peripheral T cells was lowest in patients with simple steatosis and was positively associated with anthropometric, biochemical, and histopathological features of NAFLD. In vitro co-stimulation of T cells from patients with simple steatosis induced a limited number of IFN-γ-producing CD8+ T cells. At baseline, these patients showed a low frequency of circulating type 1 CD8+ cells. Conclusions: The positive associations between TLR9 and anthropometric, clinical, and histological features and the crucial role of IFN-γ-in NAFLD suggest that limited TLR9 expression and production of IFN-γ play a protective role in patients with simple steatosi
참고문헌 (32)
- Day CP, "From fat to inflammation", Gastroenterology, 130, pp.207~210 (2006)
- Wan J, "M2 Kupffer cells promote M1 Kupffer cell apoptosis : a protective mechanism against alcoholic and nonalcoholic fatty liver disease", Hepatology, 59, pp.130~142 (2014)
- Armant MA, "Toll-like receptors : a family of pattern-recognition receptors in mammals", Genome Biol, 3, pp.3011.1~3011.6 (2002)
- Miura K, "Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1β in mice", Gastroenterology, 139, pp.323~334.e7 (2010)
- Rose II WA, "TLR9 is important for protection against intestinal damage and for intestinal repair", Sci Rep, 2, pp.574~ (2012)
- Garcia-Martinez I, "Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9", J Clin Invest, 126, pp.859~864 (2016)
- Hammond T, "Toll-like receptor(TLR)expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus", Cell Immunol, 264, pp.150~155 (2010)
- Funderburg N, "Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis", PLoS One, 3, pp.e1915~ (2008)
- Wong CK, "Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus", Clin Exp Immunol, 159, pp.11~22 (2010)
- Riordan SM, "Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis", Hepatology, 37, pp.1154~1164 (2003)
- Babu S, "Cutting edge : diminished T cell TLR expression and function modulates the immune response in human filarial infection", J Immunol, 176, pp.3885~3889 (2006)
- Kranzer K, "CpGoligodeoxynucleotides enhance T-cell receptor-triggered interferon-γproduction and up-regulation of CD69 via induction of antigenpresenting cell-derived interferon type I and interleukin-12", Immunology, 99, pp.170~178 (2000)
- Inzaugarat ME, "Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis", J Clin Immunol, 31, pp.1120~1130 (2011)
- Ilan Y, "Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody : a novel gutimmune system-based therapy for metaflammation and NASH", Clin Exp Immunol, 193, pp.275~283 (2018)
- Mridha AR, "TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival", Clin Sci (Lond), 131, pp.2145~2159 (2017)
- Chalasani N, "The diagnosis and management of non-alcoholic fatty liver disease : practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association", Hepatology, 55, pp.2005~2023 (2012)
- Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
- Brunt EM, "Nonalcoholic steatohepatitis : a proposal for grading and staging the histological lesions", Am J Gastroenterol, 94, pp.2467~2474 (1999)
- Physical status: the use and interpretation of anthropometry, "World Health Organization", World Health Organization, ~, pp.WHO Technical Report Series 854 (1995)
- Schmittgen TD, "Analyzing real-time PCR data by the comparative C(T)method", Nat Protoc, 3, pp.1101~1108 (2008)
- Tonan T, "CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis : superparamagnetic iron oxide-magnetic resonance image and pathologic correlation", J Gastroenterol Hepatol, 27, pp.789~796 (2012)
- Prunk M, "Cystatins, cysteine peptidase inhibitors, as regulators of immune cell cytotoxicity", Period Biol, 118, pp.353~362 (2016)
- Sharma RK, "Direct engagement of TLR9 ligand with T helper cells leads to cell proliferation & up-regulation of cytokines", Immunol Invest, 48, pp.79~95 (2019)
- Angulo P, "Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis", Hepatology, 30, pp.1356~1362 (1999)
- Fabbrini E, "Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity", Proc Natl Acad Sci U S A, 106, pp.15430~15435 (2009)
- Isoni CA, "cAMP activates the generation of reactive oxygen species and inhibits the secretion of IL-6 in peripheral blood mononuclear cells from type 2 diabetic patients", Oxid Med Cell Longev, 2, pp.3173~3121 (2009)
- Ghanim H, "Acute modulation of toll-like receptors by insulin", Diabetes Care, 31, pp.1827~1831 (2008)
- Chuang TH, "Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors", Nat Immunol, 5, pp.495~502 (2004)
- Zhu K, "Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis", PLoS Biol, 16, pp.e3000091~ (2018)
- Wu C, "IFN-γ primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473b", J Immunol, 193, pp.3036~3044 (2014)
- Stojsavljević S, "Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease", World J Gastroenterol, 20, pp.18070~18091 (2014)
- Inzaugarat ME, "New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans", PLoS One, 12, pp.e0172900~ (2017)